Agilon Health Inc (NYSE:AGL) shares, rose in value, with the stock price down by -3.75% to the previous day’s close as strong demand from buyers drove the stock to $5.13.
Actively observing the price movement in the last trading, the stock closed the session at $5.33. Referring to stock’s 52-week performance, its high was $26.75, and the low was $4.41. On the whole, AGL has fluctuated by 2.81% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 6.5B, with a low estimate of 1.47B and a high estimate of 1.63B. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.6B.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AGL’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of AGL currently trading nearly -1.47% and -9.40% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 47.22, while the 7-day volatility ratio is showing 7.17% which for the 30-day chart, stands at 8.82%. Furthermore, Agilon Health Inc (AGL)’s beta value is 0.53, and its average true range (ATR) is 0.43.
A comparison of Agilon Health Inc (AGL) with its peers suggests the former has fared considerably weaker in the market. AGL showed an intraday change of -3.75% in last session, and over the past year, it shrunk by -79.62%%.
Data on historical trading for Agilon Health Inc (NYSE:AGL) indicates that the trading volumes over the past 3 months, they’ve averaged 5.14 million. According to company’s latest data on outstanding shares, there are 406.39 million shares outstanding.
Nearly 26.31% of Agilon Health Inc’s shares belong to company insiders and institutional investors own 85.37% of the company’s shares. The stock has fallen by -59.12% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AGL stock heading into the next quarter.
